MeSH Review:
Neurobehavioral Manifestations
Tsai,
Yang,
Chung,
Tsai,
Tsai,
Coyle,
Axelman,
Basun,
Lannfelt,
Alarcón,
Cianfrini,
Bradley,
Sanchez,
Brooks,
Friedman,
Baethge,
Fessler,
Bastian,
Roseman,
McGwin,
Reveille,
Fraser,
Stark,
Popper,
Sunderland,
Linker,
Mirza,
Putnam,
Friedman,
Kimmel,
Bergeson,
Manetti,
Zimmermann,
Tang,
Bartko,
Cohen,
Björkqvist,
Petersén,
Bacos,
Isaacs,
Norlén,
Gil,
Popovic,
Sundler,
Bates,
Tabrizi,
Brundin,
Mulder,
Geschwind,
Loginov,
Stern,
- Identification of a locus on chromosome 14q for idiopathic basal ganglia calcification (Fahr disease). Geschwind, D.H., Loginov, M., Stern, J.M. Am. J. Hum. Genet. (1999)
- Adjuvant galantamine to risperidone improves negative and cognitive symptoms in a patient presenting with schizophrenialike psychosis after traumatic brain injury. Bennouna, M., Greene, V.B., Defranoux, L. Journal of clinical psychopharmacology. (2005)
- Behavioral effects of organophosphate in man. Levin, H.S., Rodnitzky, R.L. Clin. Toxicol. (1976)
- Cognitive symptoms and correlates of physical disability in individuals with multiple sclerosis. Fraser, C., Stark, S. The Journal of neuroscience nursing : journal of the American Association of Neuroscience Nurses. (2003)
- Progressive alterations in the hypothalamic-pituitary-adrenal axis in the R6/2 transgenic mouse model of Huntington's disease. Björkqvist, M., Petersén, A., Bacos, K., Isaacs, J., Norlén, P., Gil, J., Popovic, N., Sundler, F., Bates, G.P., Tabrizi, S.J., Brundin, P., Mulder, H. Hum. Mol. Genet. (2006)
- Effects of acute nicotine administration on behavioral inhibition in adolescents with attention-deficit/hyperactivity disorder. Potter, A.S., Newhouse, P.A. Psychopharmacology (Berl.) (2004)
- Effects of dopamine D2 receptor Ser311Cys polymorphism and clinical factors on risperidone efficacy for positive and negative symptoms and social function. Lane, H.Y., Lee, C.C., Chang, Y.C., Lu, C.T., Huang, C.H., Chang, W.H. Int. J. Neuropsychopharmacol. (2004)
- Velnacrine for the treatment of Alzheimer's disease: a double-blind, placebo-controlled trial. The Mentane Study Group. Zemlan, F.P. Journal of neural transmission (Vienna, Austria : 1996) (1996)
- Pharmacologic alternatives to psychostimulants for the treatment of attention-deficit/hyperactivity disorder. Popper, C.W. Child and adolescent psychiatric clinics of North America. (2000)
- Efficacy of cholinesterase inhibitors in the treatment of neuropsychiatric symptoms and functional impairment in Alzheimer disease: a meta-analysis. Trinh, N.H., Hoblyn, J., Mohanty, S., Yaffe, K. JAMA (2003)
- NMDA receptor hypofunction produces concomitant firing rate potentiation and burst activity reduction in the prefrontal cortex. Jackson, M.E., Homayoun, H., Moghaddam, B. Proc. Natl. Acad. Sci. U.S.A. (2004)
- Impaired synaptic plasticity in mice carrying the Huntington's disease mutation. Usdin, M.T., Shelbourne, P.F., Myers, R.M., Madison, D.V. Hum. Mol. Genet. (1999)
- Systemic lupus erythematosus in three ethnic groups. X. Measuring cognitive impairment with the cognitive symptoms inventory. Alarcón, G.S., Cianfrini, L., Bradley, L.A., Sanchez, M.L., Brooks, K., Friedman, A.W., Baethge, B.A., Fessler, B.J., Bastian, H.M., Roseman, J.M., McGwin, G., Reveille, J.D. Arthritis Rheum. (2002)
- Phenotype of schizophrenia: a review and formulation. Tamminga, C.A., Holcomb, H.H. Mol. Psychiatry (2005)
- D-serine added to clozapine for the treatment of schizophrenia. Tsai, G.E., Yang, P., Chung, L.C., Tsai, I.C., Tsai, C.W., Coyle, J.T. The American journal of psychiatry. (1999)
- A.E. Bennett Research Award. Reversal of phencyclidine-induced effects by glycine and glycine transport inhibitors. Javitt, D.C., Balla, A., Sershen, H., Lajtha, A. Biol. Psychiatry (1999)
- CSF 5-HIAA, serum cortisol, and age differentially predict vegetative and cognitive symptoms in depression. Faustman, W.O., Faull, K.F., Whiteford, H.A., Borchert, C., Csernansky, J.G. Biol. Psychiatry (1990)
- Platelet serotonin markers and depressive symptomatology. Sheline, Y.I., Bardgett, M.E., Jackson, J.L., Newcomer, J.W., Csernansky, J.G. Biol. Psychiatry (1995)
- Effectiveness of antipsychotic treatments for schizophrenia: interim 6-month analysis from a prospective observational study (IC-SOHO) comparing olanzapine, quetiapine, risperidone, and haloperidol. Dossenbach, M., Erol, A., el Mahfoud Kessaci, M., Shaheen, M.O., Sunbol, M.M., Boland, J., Hodge, A., O'Halloran, R.A., Bitter, I. The Journal of clinical psychiatry. (2004)
- Dopamine efflux in the rat nucleus accumbens evoked by dopamine receptor stimulation in the entorhinal cortex is modulated by oestradiol and progesterone. Saigusa, T., Takada, K., Baker, S.C., Kumar, R., Stephenson, J.D. Synapse (1997)
- Decreased beta-amyloid1-42 and increased tau levels in cerebrospinal fluid of patients with Alzheimer disease. Sunderland, T., Linker, G., Mirza, N., Putnam, K.T., Friedman, D.L., Kimmel, L.H., Bergeson, J., Manetti, G.J., Zimmermann, M., Tang, B., Bartko, J.J., Cohen, R.M. JAMA (2003)
- Cognitive manifestations of Huntington disease in relation to genetic structure and clinical onset. Jason, G.W., Suchowersky, O., Pajurkova, E.M., Graham, L., Klimek, M.L., Garber, A.T., Poirier-Heine, D. Arch. Neurol. (1997)
- Restoration of cognitive and motor functions by ciliary neurotrophic factor in a primate model of Huntington's disease. Mittoux, V., Joseph, J.M., Conde, F., Palfi, S., Dautry, C., Poyot, T., Bloch, J., Deglon, N., Ouary, S., Nimchinsky, E.A., Brouillet, E., Hof, P.R., Peschanski, M., Aebischer, P., Hantraye, P. Hum. Gene Ther. (2000)
- Wide range of disease onset in a family with Alzheimer disease and a His163Tyr mutation in the presenilin-1 gene. Axelman, K., Basun, H., Lannfelt, L. Arch. Neurol. (1998)
- Field dependence and the differentiation of affective states. Parkes, K.R. The British journal of psychiatry : the journal of mental science. (1981)
- High-dose glycine added to olanzapine and risperidone for the treatment of schizophrenia. Heresco-Levy, U., Ermilov, M., Lichtenberg, P., Bar, G., Javitt, D.C. Biol. Psychiatry (2004)
- Glutamate-mediated excitotoxicity and neurodegeneration in Alzheimer's disease. Hynd, M.R., Scott, H.L., Dodd, P.R. Neurochem. Int. (2004)
- Neuropsychological functioning following fetal striatal transplantation in Huntington's chorea: three case presentations. Philpott, L.M., Kopyov, O.V., Lee, A.J., Jacques, S., Duma, C.M., Caine, S., Yang, M., Eagle, K.S. Cell transplantation. (1997)
- Self-rated psychiatric symptoms in patients operated on because of primary hyperparathyroidism and in patients with long-standing mild hypercalcemia. Joborn, C., Hetta, J., Lind, L., Rastad, J., Akerström, G., Ljunghall, S. Surgery (1989)
- Effect of hormone replacement therapy on self-reported cognitive symptoms: results from the Postmenopausal Estrogen/Progestin Interventions (PEPI) trial. Reboussin, B.A., Greendale, G.A., Espeland, M.A. Climacteric : the journal of the International Menopause Society. (1998)